Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 20,303,869 $ 16,737,109
Other current assets 217,745 62,690
Total current assets 20,521,614 16,799,799
Other non-current assets 0 68,858
Total assets 20,521,614 16,868,657
Current liabilities:    
Accounts payable, accrued expenses and other current liabilities 1,580,543 1,176,666
Total current liabilities and total liabilities 1,580,543 1,176,666
Stockholders' equity:    
Common stock, par value of $0.001 per share, 40,000,000 shares authorized, 12,598,125 and 11,453,465 shares issued and outstanding at December 31, 2021, and December 31, 2020, respectively 12,598 11,453
Additional paid-in capital 60,220,016 47,873,570
Accumulated other comprehensive loss (3,160) (7,873)
Accumulated deficit (41,288,383) (32,185,159)
Total stockholders' equity 18,941,071 15,691,991
Total liabilities and stockholders' equity $ 20,521,614 $ 16,868,657